Aquestive Therapeutics, Inc. AQST
3.59 USD 0.00 (+0.14%)
Nov 12, 2026, 3:19 PM EST
3.45 Day range 3.68
2.93 52-week range 6.74
- YTD
- -44.50%
- 1 year
- -35.75%
News
globenewswire.com Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference WARREN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a biopharmaceutical company advancing medicines to bring meaningful…
globenewswire.com Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting WARREN, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to bring meaningful…
benzinga.com Aquestive Therapeutics Q3 2026 Earnings Call Transcript Aquestive Therapeutics (NASDAQ:AQST) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $51.040M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.
benzinga.com Aquestive Therapeutics Q3 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.557M Miss $11.017M Estimate Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over…
benzinga.com FDA Accepts Aquestive Therapeutics’ Anaphylm NDA Resubmission; PDUFA Goal Action Date Set For March 16, 2027 FDA accepted the resubmission as complete and classified it as a Class 2 responsePrescription Drug User Fee Act (PDUFA) goal action date set for March 16, 2027Ex-U.S. strategy remains on track with…
benzinga.com Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.- benzinga.com Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027 Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually…
benzinga.com Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment Aquestive Therapeutics has resubmitted its New Drug Application to the FDA for Anaphylm, a sublingual film for severe allergic reactions.- benzinga.com HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains $10 price target.
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $50.584 million estimate.
benzinga.com Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study Aquestive Therapeutics reports positive study results for Anaphylm sublingual film, paving the way for a Q3 FDA resubmission.
benzinga.com Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
benzinga.com Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday U.S. stocks rose, with Dow Jones up 300 points. STAA shares surged after better-than-expected results. Other big gainers include POET, STUB, MSC, ARX, CSCO, PCT, WOLF, CPA, ONDS, KLAR, and RDW.
benzinga.com Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript 
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $48.072M Est Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $48.072 million estimate.
benzinga.com Aquestive Therapeutics Q1 EPS $(0.07) Beats $(0.15) Estimate, Sales $14.446M Beat $10.896M Estimate Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 70.83 percent increase over losses…
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com Aquestive Therapeutics Completes In-Person Type A Meeting With FDA Regarding Resubmission Of NDA For Anaphylm Sublingual Film For Treatment Of Type 1 Allergic Reactions, Including Anaphylaxis Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science…
benzinga.com Aquestive Therapeutics Q4 Earnings Assessment - benzinga.com Aquestive Therapeutics Sees FY2026 Sales $46.000M-$50.000M vs $49.888M Est Aquestive Therapeutics (NASDAQ:AQST) sees FY2026 sales of $46.000 million-$50.000 million vs $49.888 million analyst estimate.
- benzinga.com Aquestive Therapeutics Q4 Adj. EPS $(0.15) Misses $(0.13) Estimate, Sales $13.015M Miss $13.284M Estimate Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 12.78 percent. This is a 21.05 percent increase over…
- benzinga.com Earnings Scheduled For March 4, 2026
benzinga.com A Preview Of Aquestive Therapeutics's Earnings 
benzinga.com What Does the Market Think About Aquestive Therapeutics Inc? 
benzinga.com What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment? Aquestive received an FDA rejection for its allergy film due to safety and use issues. The company plans new studies and targets resubmission in 2026.- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday - benzinga.com Aquestive Therapeutics Receives CRL From FDA For NDA Seeking Approval Of Anaphylm Sublingual Film For Treatment Of Type I Allergic Reactions, Including Anaphylaxis, In Patients Weighing 30kg Or More Deficiencies limited to packaging and administration Company believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026 Remains well-capitalized and anticipates ending…
- benzinga.com Peering Into Aquestive Therapeutics Inc's Recent Short Interest
benzinga.com 10 Health Care Stocks Whale Activity In Today's Session 
benzinga.com Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
benzinga.com Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dow Edges Higher; US Economy Adds 50,000 Jobs In December - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
- benzinga.com Earnings Scheduled For August 11, 2025
- benzinga.com Earnings Scheduled For May 12, 2025
- benzinga.com Earnings Scheduled For March 5, 2025
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com Dow Surges 350 Points; Fed Holds Rates Steady U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also…